Format

Send to:

Choose Destination
See comment in PubMed Commons below
Genes Dev. 2015 May 1;29(9):934-47. doi: 10.1101/gad.258350.115.

Loss of the RNA polymerase III repressor MAF1 confers obesity resistance.

Author information

  • 1Center for Integrative Genomics, Faculty of Biology and Medicine, University of Lausanne, 1015 Lausanne, Switzerland;
  • 2Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York 10461, USA;
  • 3Mouse Metabolic Evaluation Facility, Center for Integrative Genomics, University of Lausanne, 1015 Lausanne, Switzerland;
  • 4Center for Integrative Genomics, Faculty of Biology and Medicine, University of Lausanne, 1015 Lausanne, Switzerland; Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland;
  • 5Division of Endocrinology, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461, USA;
  • 6Division of Endocrinology, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461, USA; Diabetes Research Center, Albert Einstein College of Medicine, Bronx, New York 10461, USA;
  • 7Laboratory for Integrative and Systems Physiology, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland.
  • 8Center for Integrative Genomics, Faculty of Biology and Medicine, University of Lausanne, 1015 Lausanne, Switzerland; Mouse Metabolic Evaluation Facility, Center for Integrative Genomics, University of Lausanne, 1015 Lausanne, Switzerland;
  • 9Center for Integrative Genomics, Faculty of Biology and Medicine, University of Lausanne, 1015 Lausanne, Switzerland; nouria.hernandez@unil.ch ian.willis@einstein.yu.edu.
  • 10Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York 10461, USA; Diabetes Research Center, Albert Einstein College of Medicine, Bronx, New York 10461, USA; nouria.hernandez@unil.ch ian.willis@einstein.yu.edu.

Abstract

MAF1 is a global repressor of RNA polymerase III transcription that regulates the expression of highly abundant noncoding RNAs in response to nutrient availability and cellular stress. Thus, MAF1 function is thought to be important for metabolic economy. Here we show that a whole-body knockout of Maf1 in mice confers resistance to diet-induced obesity and nonalcoholic fatty liver disease by reducing food intake and increasing metabolic inefficiency. Energy expenditure in Maf1(-/-) mice is increased by several mechanisms. Precursor tRNA synthesis was increased in multiple tissues without significant effects on mature tRNA levels, implying increased turnover in a futile tRNA cycle. Elevated futile cycling of hepatic lipids was also observed. Metabolite profiling of the liver and skeletal muscle revealed elevated levels of many amino acids and spermidine, which links the induction of autophagy in Maf1(-/-) mice with their extended life span. The increase in spermidine was accompanied by reduced levels of nicotinamide N-methyltransferase, which promotes polyamine synthesis, enables nicotinamide salvage to regenerate NAD(+), and is associated with obesity resistance. Consistent with this, NAD(+) levels were increased in muscle. The importance of MAF1 for metabolic economy reveals the potential for MAF1 modulators to protect against obesity and its harmful consequences.

© 2015 Bonhoure et al.; Published by Cold Spring Harbor Laboratory Press.

KEYWORDS:

MAF1; RNA polymerase III; autophagy; futile cycling; metabolic efficiency; obesity; polyamines

PMID:
25934505
[PubMed - indexed for MEDLINE]
PMCID:
PMC4421982
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk